drugset / Trial / NCT02061813

Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

NCT02061813

Phase 1 Completed 40 enrolled Dr. Reddy's Laboratories Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.

Timeline

Start
2014-01
Primary completion
2014-01
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Abametapir Small molecule 0.2 ml Topical
Subject Abametapir Small molecule 0.74 % Topical
Background Sodium Lauryl Sulfate Small molecule 0.2 % Topical
Background Sodium Lauryl Sulfate Small molecule 0.2 ml Topical